LTI-01-2001 A Phase 2 randomized placebo controlled double blind dose ranging study evaluating LTI-01 in patients with infected non-draining pleural effusions
Clinical Trial Grant
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
Lung Therapeutics, Inc.
Start Date
May 5, 2020
End Date
April 30, 2023
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
Lung Therapeutics, Inc.
Start Date
May 5, 2020
End Date
April 30, 2023